What should happen before you choose hip care?

Has basic care had a fair try?

Basic care often includes steady movement, gentle strength exercises, and shorter hard activities. A printed exercise sheet isn't enough when the hip keeps getting worse. Walking distance may need to fall before it can grow again. Ask your doctor which exercises fit and whether a pain reliever is safe.

Give each change enough time to show whether it helps. Don't add longer walks and harder games during the same week. Note what the hip feels like that evening and the next morning. Bring those notes if soreness keeps limiting the day.

What will the visit cover?

First, the doctor asks when your ache began and where it sits. The exam checks motion, strength, and the spots that hurt. They may use an X-ray to look for changes in the joint. The talk can then cover price, recovery, and the daily task you want back.

Does a planned surgery change the choice?

Tell the clinic when a surgeon is already discussing hip replacement. A corticosteroid procedure puts steroid medicine into the sore area with a needle. If done too close to replacement, it may raise the chance of infection afterward. The clinic and surgeon need to speak before either office sets the timing.

Ask which office will make that call and share the records. Give both offices the date and type of any recent hip care. Don't assume one office already knows what the other did. Clear timing protects the surgery plan from a missed detail.

Which warning signs need faster care?

Seek urgent medical help for fever with a hot, sharply sore hip. Get prompt care when a fall leaves the leg unable to bear weight. Sudden numbness, weakness, or losing control of the bladder or bowels also needs fast help. A regular clinic visit can't safely replace urgent care for those signs.

Without those signs, record what eases or worsens your hip. Keep walking and exercise within an amount the joint can manage. QC Kinetix in Chandler provides consultations about soreness and regenerative treatments, meaning non-surgical choices made from blood or tissue.

Sources

1. In a three-arm randomized trial of 204 people with MRI-confirmed gluteal tendinopathy, an eight-week physiotherapist-led education and exercise programme produced success on global rating of change in 51/66 participants at 8 weeks versus 38/65 for a single corticosteroid injection and 20/68 for wait-and-see. Education plus exercise beat the injection at 8 weeks (risk difference 19.9%) and still beat it at 52 weeks (20.4%).

   Mellor R, et al. — Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial.. BMJ, 2018. DOI: 10.1136/bmj.k1662.

2. A meta-analysis of 28 studies covering 480,532 patients found a significant association between pre-operative intra-articular corticosteroid injection and periprosthetic joint infection after TOTAL HIP arthroplasty (OR 1.55, P=.001), with higher risk when the injection was given within 3 months of surgery (OR 1.20, P=.045). No such association was found for knee arthroplasty. Timing of a hip injection matters if replacement may follow.

   Albanese J, et al. — Infection Risk Increases After Total Hip Arthroplasty Within 3 Months Following Intra-Articular Corticosteroid Injection. A Meta-Analysis on Knee and Hip Arthroplasty.. Journal of Arthroplasty, 2023. DOI: 10.1016/j.arth.2022.12.038.

3. Pooled analysis of national joint registries (Australia and Finland, 215,676 hip replacements) put 25-year all-cause construct survival at 57.9% (95% CI 57.1-58.7); pooled case series gave 77.6% (95% CI 76.0-79.2). The authors conclude patients and surgeons can expect a hip replacement to last 25 years in around 58% of patients.

   Evans JT, et al. — How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.. The Lancet, 2019. DOI: 10.1016/S0140-6736(18)31665-9.

4. A meta-analysis of 9 Level-1 trials (671 patients) of adipose stromal vascular fraction and adipose-derived MSC injections for knee OA found SVF superior to saline or hyaluronic acid on pain and function at 3, 6 and 12 months - but INFERIOR to corticosteroid at 3 months, no different at 6, and only comparable or slightly superior at 12. Adipose-derived MSCs beat saline and conservative care but showed no significant difference versus HA. No serious adverse events were attributed to the injections themselves, though complications associated with the LIPOSUCTION step were observed.

   Han JH, et al. — Intra-articular Stromal Vascular Fraction and Mesenchymal Stem Cell Injections Show Variable Efficacy and Higher Potential Complications Compared to Corticosteroid and Hyaluronic Acid in Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials.. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association, 2025. DOI: 10.1016/j.arthro.2025.01.050.

5. In a 2-year RCT, intra-articular triamcinolone given every 12 weeks for knee OA produced significantly GREATER cartilage volume loss than saline, with no significant pain benefit. The most widely used joint injection in medicine is itself associated with structural harm on repeat dosing - relevant context when a clinic frames a biologic as 'the alternative to steroid shots'.

   McAlindon TE, et al. — Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.. JAMA, 2017. DOI: 10.1001/jama.2017.5283.